- 全部删除
 
您的购物车当前为空
PF-06447475 是LRRK2激酶选择性抑制剂,可通透血脑屏障,能够抑制 WT LRRK (IC50:3 nM) 和 G2019S LRRK2 (IC50:11 nM) 。它可用于研究帕金森病 (PD) 。


为众多的药物研发团队赋能,
让新药发现更简单!
PF-06447475 是LRRK2激酶选择性抑制剂,可通透血脑屏障,能够抑制 WT LRRK (IC50:3 nM) 和 G2019S LRRK2 (IC50:11 nM) 。它可用于研究帕金森病 (PD) 。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 197  | In stock | |
| 5 mg | ¥ 467  | In stock | |
| 10 mg | ¥ 738  | In stock | |
| 25 mg | ¥ 1,390  | In stock | |
| 50 mg | ¥ 2,090  | In stock | |
| 100 mg | ¥ 3,070  | In stock | |
| 200 mg | ¥ 4,360  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 451  | In stock | 
PF-06454589 相关产品
| 产品描述 | PF-06454589 is a potent inhibitor of LRRK2.  | 
| 分子量 | 284.32 | 
| 分子式 | C14H16N6O | 
| CAS No. | 1527473-30-8 | 
| Smiles | Cn1cc(cn1)-c1c[nH]c2ncnc(N3CCOCC3)c12 | 
| 密度 | 1.49 g/cm3 (Predicted) | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 9 mg/mL (31.65 mM), Sonication is recommended.   | |||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||
评论内容